CI — Stock Film
STOCK FILMSCENE 1/11CI · $274
Stock Expert AI presents
CI
Cigna Corporation
~4 min film100% real numbers0 jargon
WHAT DOES THIS COMPANY DO?
Cigna Corporation. A quick introduction.

On the stock market since 1982, it operates in the world of health and science. It has 66,685 employees. Now — the numbers.

on the stock market since 1982
67K employees
$74B market value
Revenue last year:
$0
The net profit left over:
$0
Out of every $100 in sales, $2 stays as net profit.
THE SLICE THAT TURNS INTO PROFIT: 2%

This is an established company with proven profits.

WHERE DOES THE MONEY COME FROM?
83%Evernorth
Evernorth 83%Cigna Healthcare 17%
83% of all revenue comes from a single line: Evernorth.

That much dependence is a risk in itself: if this one line weakens, the whole company feels it directly.

THE SALES TREND
Sales are growing, year after year.

Average growth of 12% a year over the last 4 years. Every year shown ended in profit.

$174B
2021
$181B
2022
$195B
2023
$247B
2024
$275B
2025
INSIDE THE REPORT CARD

We compared this company with its own sector across five subjects.

A score of 50 means class average.

BUSINESS QUALITY
76
strong

Clearly above the class average — a step short of the very top.

FINANCIAL STRENGTH
49
weak

Clearly below the class average.

VALUATION
93
very strong

The price looks reasonable next to what the company earns.

GROWTH
70
strong

Clearly above the class average — a step short of the very top.

PRICE MOMENTUM
43
weak

Clearly below the class average.

WORTH WATCHING

Price Momentum: The stock has lagged the market in recent months; investor interest is weak right now.

Financial Strength: The cash-and-debt balance is thin; the buffer for hard times is slim.

THE COUNCIL REVIEW
9

angles, checked one by one.

The 2 that stand out are on screen; the rest came back neutral.

The council scores out of 10; report-card grades are out of 100.

WEAK SPOTS
The stock has lost its spark0/10
Costs eat into the margin4/10
WORTH WATCHING

Cost Efficiency: As sales grow, profit fails to keep the same pace.

THE FIVE-YEAR JOURNEY
Below the peak, but no collapse.

The stock trades 25% below its peak. The market has trimmed its expectations for the company.

1
THE BRIGHT SIDE · 1/3
Sales keep climbing

Over the last 3 years, sales grew about 15% a year on average.

2
THE BRIGHT SIDE · 2/3
Delivers on expectations

It met or beat analyst expectations in 7 of the last 8 quarters — consistency is a promise kept.

3
THE BRIGHT SIDE · 3/3
Executives are buying their own stock

Over the last 12 months, company executives reported 42 buys and 38 sells. Management buying with its own money is usually read as a good sign.

1
THE RISKS · 1/3
The stock has lost its spark

Buyers haven’t stepped back in yet; the price hasn’t found its footing. Report-card grade: 43/100. For a turnaround signal, the stock first needs to close the gap with the market.

2
THE RISKS · 2/3
A thin financial cushion

The balance sheet offers little cushion against a rough stretch. Report-card grade: 49/100.

3
THE RISKS · 3/3
Costs eat into the margin

Costs swallow the gains that sales growth brings in. Council score: 4/10.

FINALE · THE GRADE
B
0 / 100 · MoonshotScore

On our five-subject report card, CI sits near the top of the class. A high grade doesn’t mean “guaranteed win” — it means “the evidence looks strong for now.”

The takeaway: CI is an established business that has proven its profits for years. The real debate here isn’t the price — it’s whether the company can keep up this pace.

The total grade weighs these five subjects against the sector — it isn’t a simple average of the five.

What would you like to do next?
Open the stock page →
This was a film — not investment advice.
Data: FMP & company filings
Aug 21, 2026 · stockexpertai.com · Stock Film